InvestorsHub Logo
Followers 25
Posts 2345
Boards Moderated 0
Alias Born 06/20/2020

Re: Marksch1 post# 161054

Friday, 04/23/2021 9:55:39 AM

Friday, April 23, 2021 9:55:39 AM

Post# of 233221

Cytodyn says "give us your sickest, weakest patients, people with 1 foot in the grave, and we will improve their outcomes"


That might have been true with the original eINDS done at Montefiori but leronlimab did have exclusions in their trial for patients who were too sick:

https://clinicaltrials.gov/ct2/show/NCT04347239
None of the following: Respiratory failure (defined by endotracheal intubation and mechanical ventilation, oxygen delivered by high-flow nasal cannula, noninvasive positive pressure ventilation, or clinical diagnosis of respiratory failure in setting of resource limitations), Septic shock (defined by SBP < 90 mm Hg, or Diastolic BP < 60 mm Hg), Multiple organ dysfunction/failure

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News